Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH
- PMID: 21031597
- PMCID: PMC3151547
- DOI: 10.1002/humu.21387
Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH
Abstract
Dermal neurofibromas (dNFs) are benign tumors of the peripheral nervous system typically associated with Neurofibromatosis type 1 (NF1) patients. Genes controlling the integrity of the DNA are likely to influence the number of neurofibromas developed because dNFs are caused by somatic mutational inactivation of the NF1 gene, frequently evidenced by loss of heterozygosity (LOH). We performed a comprehensive analysis of the prevalence and mechanisms of LOH in dNFs. Our study included 518 dNFs from 113 patients. LOH was detected in 25% of the dNFs (N = 129). The most frequent mechanism causing LOH was mitotic recombination, which was observed in 62% of LOH-tumors (N = 80), and which does not reduce the number of NF1 gene copies. All events were generated by a single crossover located between the centromere and the NF1 gene, resulting in isodisomy of 17q. LOH due to the loss of the NF1 gene accounted for a 38% of dNFs with LOH (N = 49), with deletions ranging in size from ∼80 kb to ∼8 Mb within 17q. In one tumor we identified the first example of a neurofibroma-associated second-hit type-2 NF1 deletion. Analysis of the prevalence of mechanisms causing LOH in dNFs in individual patients (possibly under genetic control) will elucidate whether there exist interindividual variation.
© 2010 Wiley-Liss, Inc.
Figures





Similar articles
-
Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.J Invest Dermatol. 2009 Mar;129(3):615-21. doi: 10.1038/jid.2008.274. Epub 2008 Sep 18. J Invest Dermatol. 2009. PMID: 18800150
-
Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.Genes Chromosomes Cancer. 2000 Aug;28(4):425-31. Genes Chromosomes Cancer. 2000. PMID: 10862051
-
Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.Hum Genet. 2001 May;108(5):416-29. doi: 10.1007/s004390100514. Hum Genet. 2001. PMID: 11409870
-
Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.J Invest Dermatol. 2023 Aug;143(8):1369-1377. doi: 10.1016/j.jid.2022.12.027. Epub 2023 Jun 15. J Invest Dermatol. 2023. PMID: 37318402 Free PMC article. Review.
-
Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?Childs Nerv Syst. 2022 Apr;38(4):705-713. doi: 10.1007/s00381-021-05436-w. Epub 2022 Jan 8. Childs Nerv Syst. 2022. PMID: 34997843 Free PMC article. Review.
Cited by
-
Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells.Sci Data. 2018 Jun 12;5:180106. doi: 10.1038/sdata.2018.106. Sci Data. 2018. PMID: 29893754 Free PMC article.
-
Schwannomatosis patient who was followed up for fifteen years: A case report.World J Clin Cases. 2022 Jul 16;10(20):6981-6990. doi: 10.12998/wjcc.v10.i20.6981. World J Clin Cases. 2022. PMID: 36051151 Free PMC article.
-
Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.Hum Genomics. 2011 Oct;5(6):623-90. doi: 10.1186/1479-7364-5-6-623. Hum Genomics. 2011. PMID: 22155606 Free PMC article. Review.
-
Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.Genes Chromosomes Cancer. 2012 May;51(5):429-37. doi: 10.1002/gcc.21928. Epub 2012 Jan 17. Genes Chromosomes Cancer. 2012. PMID: 22250039 Free PMC article.
-
Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.Hum Genomics. 2012 Sep 4;6(1):18. doi: 10.1186/1479-7364-6-18. Hum Genomics. 2012. PMID: 23244685 Free PMC article.
References
-
- Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet. 2000;9:237–247. - PubMed
-
- Bishop AJ, Schiestl RH. Role of homologous recombination in carcinogenesis. Exp Mol Pathol. 2003;74:94–105. - PubMed
-
- Carey JC, Laub JM, Hall BD. Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects Orig Artic Ser. 1979;15:271–281. - PubMed
-
- Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 1983;305:779–784. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous